相关实验视频

Updated: Jan 18, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

在糖尿病视网膜病变患者中评估C反应性蛋白/白蛋白比率

Şaban Kılıç¹, Emre Aydın¹, Çiğdem Deniz Genç¹

¹Department of Ophthalmology, Samsun Education and Research Hospital, Kısla, Barıs Blv. No:199, 55090 Samsun, Turkey.

Diagnostics (Basel, Switzerland)

|September 13, 2025

概括

反应性C蛋白/白蛋白 (CRP/白蛋白) 的比率有效地表明炎症和糖尿病视网膜病变 (DR) 的严重程度. 治疗后降低这种比率意味着改善了DR进展和炎症控制.

科学领域:

眼科医生眼科眼科
临床生物化学临床生物化学
炎症研究炎症研究

背景情况:

糖尿病视网膜病变 (DR) 是导致视力丧失的主要原因.
炎症在DR的发病和进展中起着至关重要的作用.
需要新的生物标志物来评估DR的炎症和疾病严重程度.

研究的目的:

调查C反应蛋白/白蛋白 (CRP/白蛋白) 比例与DR严重程度之间的关系.
评估CRP/白蛋白比作为炎症和DR进展的生物标志物.
评估治疗对CRP/白蛋白比率和其他炎症标志物的影响.

主要方法:

一项前性,横截面研究,涉及158名DR患者和150名健康对照.
临床,眼科 (视觉敏度,OCT) 和实验室 (炎症和血糖标记) 的评估.
计算CRP/白蛋白比率和统计分析,包括接收器运行特征 (ROC) 分析.

主要成果:

与对照组相比,DR患者的CRP/白蛋白比率和其他炎症标志物 (NLR,MLR,PLR,SII) 显著增加.
在治疗后,CRP/白蛋白比率,CRP水平,以及NLR,PLR,SII显著下降,与改善的视网膜厚度和HbA1c相关.
ROC分析显示,DR严重性中CRP/白蛋白的高预测准确性 (AUC=0.963).

结论:

CRP/白蛋白比率是糖尿病视网膜病变中炎症和疾病进展的重要生物标志物.
治疗后CRP/白蛋白和其他炎症标志物的降低强调了炎症控制在治疗DR中的重要性.
CRP/白蛋白比率显示出作为监测DR的临床工具的潜力.

关键词:

在CRP/白蛋白比率上,CRP/白蛋白比率是糖尿病视网膜病变糖尿病视网膜病变疾病的严重程度.血糖控制血糖控制血糖控制炎症生物标志物炎症生物标志物

更多相关视频

Retinal Pathophysiological Evaluation in a Rat Model

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

相关概念视频

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Serum Studies: Renal Function Tests

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.